The team's study was published in the journal F&S Science. Treating fibroids is often invasive and expensive, costing patients and their insurers billions of dollars each year, according to the ...
Introduction: Uterine leiomyomas, or fibroids, are prevalent benign tumors affecting up to 70% of reproductive-age women in the United States, significantly impacting pr ...
Profound is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue.